Quantifying the effect of natalizumab on the total disability burden of MS patients in AFFIRM using an exploratory area under the curve analysis

The requested reference [80ab663485a5dcb2c5b93d334a108fbf6752c8c5] no longer exists in our database. It has been replaced by the current reference: [cab09fe4f737172193600c60caad87a49a188e01]

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2014
This article has no abstract
Epistemonikos ID: 6186d0f67a46011bf942da4f05014b6761fe0918
First added on: Apr 30, 2026